Cargando…
Identification of colorectal cancers with defective DNA damage repair by immunohistochemical profiling of mismatch repair proteins, CDX2 and BRCA1
Colorectal cancer (CRC) is a complex disease as shown by consensus classification. The present study attempted to identify subtypes with known prognostic markers for better clinical management. A total of 72 CRC tumors were examined for the expression of mismatch repair (MMR) proteins, along with ca...
Autores principales: | Rajarajan, Savitha, C.E, Anupama, Jose, Betsy, Correa, Marjorie, Sengupta, Sagar, Prabhu, Jyothi S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484731/ https://www.ncbi.nlm.nih.gov/pubmed/32953111 http://dx.doi.org/10.3892/mco.2020.2128 |
Ejemplares similares
-
Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer
por: Korlimarla, Aruna, et al.
Publicado: (2016) -
Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair‐deficient colorectal cancer
por: Ryan, É. J., et al.
Publicado: (2018) -
Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer
por: Vlahović, Ivan, et al.
Publicado: (2023) -
Assessment of mismatch repair deficiency, CDX2, beta-catenin and E-cadherin expression in colon cancer: molecular characteristics and impact on prognosis and survival – an immunohistochemical study
por: Melincovici, Carmen Stanca, et al.
Publicado: (2020) -
CDX-1/CDX-2 Expression Is a Favorable Prognostic Factor in Epstein-Barr Virus-Negative, Mismatch Repair-Proficient Advanced Gastric Cancers
por: Kim, Kyeongmin, et al.
Publicado: (2021)